Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+35.9%
5Y CAGR+32.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+35.9%/yr
vs +20.0%/yr prior
5Y CAGR
+32.2%/yr
Recent acceleration
Acceleration
+16.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $315.39M | +37.2% |
| 2024 | $229.88M | +69.6% |
| 2023 | $135.54M | +7.9% |
| 2022 | $125.61M | +7.2% |
| 2021 | $117.15M | +49.9% |
| 2020 | $78.17M | -10.9% |
| 2019 | $87.70M | +44.6% |
| 2018 | $60.64M | -4.3% |
| 2017 | $63.39M | +41.6% |
| 2016 | $44.77M | - |